FDA approves first brain stimulation device for home depression treatment. Flow Neuroscience's FL-100 headset uses electrical ...
The FDA clears ProlivRx at-home neuromodulation for adjunctive major depressive disorder treatment in adults with inadequate antidepressant response.
More than 20% of all patients treated with the implant had essentially no symptoms of depression after two years, researchers ...
Instead, experts may use the term, or TRD for short, to characterize depression unimproved by one or more validated, ...
Depression, one of the most prevalent mental health disorders worldwide, is characterized by persistent feelings of sadness, impaired daily functioning and a loss of interest in daily activities, ...
MedPage Today on MSN
FDA Approves At-Home Device for Treatment-Resistant Depression
The FDA approved a prescription at-home brain neuromodulation therapy as an adjunctive depression treatment for adults, maker ...
Depression is not only a disorder of mood but also a condition that affects the heart and blood vessels, and can carry ...
News-Medical.Net on MSN
Vagus nerve stimulation shows lasting benefit in treatment-resistant depression
Findings reveal that vagus nerve stimulation leads to lasting benefits in treatment-resistant depression, improving function ...
About 20% of U.S. adults experience major depression in their lifetime. For most people, symptoms improve within a few ...
A review of recent studies suggests exercise may treat depression as effectively as therapy or antidepressants, offering an ...
Researchers from Hiroshima University in Japan and collaborating institutions have found that adults with asthma who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results